Correlations between thyroid cancer and GLP1 agonists have been seen in animal studies and in some human studies.
Overall these aren’t recommended for those with thyroid cancers (or with genetics that cause increased risk for thyroid cancers) as the risk of cancer far outweighs any potential benefits from treating weight loss or diabetes (esp when there are alternative diabetes medications)
Latest Answers